Cargando…
Long-term outcomes in patients with immune checkpoint inhibitor induced pneumonitis
INTRODUCTION: Immune checkpoint inhibitors (ICI) have improved outcomes for patients with many malignancies. However, these treatments are associated with immune-related adverse events, including pulmonary toxicity (pneumonitis). Pneumonitis is associated with significant short-term morbidity and mo...
Autores principales: | Davis Puente, Andrea, Johnson, Douglas B, Bastarache, Julie A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083847/ http://dx.doi.org/10.1136/bmjresp-2022-001342 |
Ejemplares similares
-
Chronic immune checkpoint inhibitor pneumonitis
por: Naidoo, Jarushka, et al.
Publicado: (2020) -
Respiratory and allergic outcomes among 5-year-old children exposed to pesticides
por: Islam, Jessica Y, et al.
Publicado: (2023) -
Effect modification by age of the association between obstructive lung diseases, smoking, and COVID-19 severity
por: Moschovis, Peter P, et al.
Publicado: (2021) -
Maternal iron status during pregnancy and respiratory and atopic outcomes in the offspring: a Mendelian randomisation study
por: Bédard, Annabelle, et al.
Publicado: (2018) -
Patient outcomes following emergency admission to hospital for COVID-19 compared with influenza: retrospective cohort study
por: Woodcock, Thomas, et al.
Publicado: (2023)